Mead Johnson Nutrition CO (MJN) : Vgi Partners Pty Ltd scooped up 112,418 additional shares in Mead Johnson Nutrition CO during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 674,008 shares of Mead Johnson Nutrition CO which is valued at $48,697,078.Mead Johnson Nutrition CO makes up approximately 12.98% of Vgi Partners Pty Ltd’s portfolio.
Other Hedge Funds, Including , Donaldson Capital Management reduced its stake in MJN by selling 650 shares or 19.99% in the most recent quarter. The Hedge Fund company now holds 2,601 shares of MJN which is valued at $187,922. Mead Johnson Nutrition CO makes up approx 0.03% of Donaldson Capital Management’s portfolio.Teacher Retirement System Of Texas reduced its stake in MJN by selling 6,157 shares or 46.13% in the most recent quarter. The Hedge Fund company now holds 7,189 shares of MJN which is valued at $522,497.Global X Management Co boosted its stake in MJN in the latest quarter, The investment management firm added 364 additional shares and now holds a total of 390 shares of Mead Johnson Nutrition CO which is valued at $28,345.Nippon Life Global Investors Americas reduced its stake in MJN by selling 3,770 shares or 8.39% in the most recent quarter. The Hedge Fund company now holds 41,190 shares of MJN which is valued at $3,013,460. Mead Johnson Nutrition CO makes up approx 0.29% of Nippon Life Global Investors Americas’s portfolio.Manning Napier Advisors reduced its stake in MJN by selling 270 shares or 0.35% in the most recent quarter. The Hedge Fund company now holds 77,550 shares of MJN which is valued at $5,784,455. Mead Johnson Nutrition CO makes up approx 0.04% of Manning Napier Advisors’s portfolio.
Mead Johnson Nutrition CO closed down -0.59 points or -0.82% at $71 with 14,91,127 shares getting traded on Monday. Post opening the session at $71.4, the shares hit an intraday low of $70.84 and an intraday high of $71.57 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Oct 27, 2016. Analyst had a consensus of $0.86. The company had revenue of $937.50 million for the quarter, compared to analysts expectations of $929.82 million. The company’s revenue was down -4.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.77 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Downgraded by JP Morgan to ” Neutral” on Oct 28, 2016. Shares were Reiterated by Deutsche Bank on Oct 28, 2016 to “Hold” and Lowered the Price Target to $ 78 from a previous price target of $85 .
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.